Whats POH's cut of commercialised revenue from all the breaches? This is the area where i think the case is weak.
The agreement is still in full force so any future revenue from products developed and commercialised, we are still entitled to a cut. Can't see much going ahead after this debacle.
I live in hope that we're awarded substantially more but am staying grounded to accept a very modest amount to avoid cap raising again in the next three years.
Ann: Phosphagenics Mylan Arbitration Hearing Concluded, page-143
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 46009211 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 46070683 | 28 |
View Market Depth
| Last trade - 11.05am 30/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable